510(k) K040101

MODIFICATION TO DIADEXUS PLAC TEST by Diadexus, Inc. — Product Code NOE

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 5, 2004
Date Received
January 20, 2004
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2
Device Class
Class II
Regulation Number
866.5600
Review Panel
IM
Submission Type

The Lipoprotein-associated Phospholipase A2, Immunoassay, System, Test, is intended to measure lipoprotein-associated phospholipase A2 in human plasma in conjunction with clinical evaluation and other patient risk factors including biochemical analyses as an aid in predicting risk for coronary heat disease. This device differs from the classification regulation in that it is a different analyte, thus a NEW marker for predicting risk of coronary heart disease. This device is measuring an enzyme that is produced by macrophages where as the regulation is for the measurement of a lipoprotein.